Beyond the Headlines: What the 2026 World Drug Report Means for Our Work

Every year, the United Nations Office on Drugs and Crime (UNODC) World Drug Report provides a comprehensive overview of the global drug situation. It offers far more than statistics by going further to help us understand how drug markets are evolving, where the greatest health and public safety challenges lie, and how our professional responses must continue to adapt.

On June 30th, 2026, ISSUP had the pleasure of welcoming Giovanna Campello, Chief of the Prevention, Treatment and Rehabilitation Section at UNODC, for a webinar unpacking the key findings of the 2026 World Drug Report and reflecting on asscoiated implications for professionals working across prevention, treatment, recovery , policy, law enforcement and criminal justice.  

One of the strongest messages from the discussion was that the global drug landscape is becoming increasingly dynamic and complex. Drug markets continue to diversify, with expanding availability of synthetic drugs, increasingly potent substances, new psychoactive substances, and more widespread poly-drug use. Drug mixtures, often consumed unknowingly, are adding further complexity for clinicians, forensic services, toxicologists, law enforcement agencies and policymakers alike.  

At the same time, many of the longstanding public health challenges remain. Cannabis continues to be the most commonly used drug globally, while most people living with drug use disorders still do not receive treatment. Women continue to experience disproportionately severe health and social consequences despite lower prevalence of use, and HIV and hepatitis C remain major contributors to drug-related mortality among people who inject drugs.  

For those working in prevention, the report reinforces the importance of investing in evidence-based interventions early in life. Adolescence remains a particularly important developmental period, and while encouraging declines in adolescent cannabis use have been observed in some higher-income countries, levels of drug use among young people remain concerning globally. Prevention therefore remains one of the most important long-term investments countries can make.  

For treatment and recovery professionals, the discussion highlighted the growing need for services that can respond effectively to stimulant use disorders, increasingly complex patterns of poly-drug use, and the expanding presence of synthetic opioids, including nitazenes. This reinforces the importance of strengthening recovery-oriented systems of care while ensuring services are responsive to the needs of women and other underserved populations.  

The webinar also devoted considerable attention to this year’s special chapter on drug use, safety and security. One of its most important messages is that the relationship between drug use and crime is complex and should never be viewed as deterministic. While drug use may be associated with acquisitive crime, violence and victimisation, these relationships are shaped by broader social, policy and environmental factors rather than by drug use alone. This distinction is particularly important for professionals working across policing, criminal justice and community safety, reminding us that balanced, evidence-informed approaches integrating both public health and public safety remain essential.  

The discussion that followed reflected the diversity of ISSUP’s global membership. Participants raised thoughtful questions about improving surveillance and data quality, responding to emerging substances such as medetomidine and nitazenes, addressing the treatment gap, strengthening women-centred services, managing poly-drug use, involving families in recovery, improving international collaboration, and preparing the workforce for increasingly complex drug markets. These conversations underscored the value of bringing together professionals from different sectors and regions to engage with emerging evidence through the lens of practice.  

Perhaps one of the most exciting developments accompanying this year’s report is the enhanced interactive World Drug Report data platform. Rather than simply reading the report, professionals can now explore trends, compare regions, examine specific substances and better understand changing drug market dynamics through an accessible, interactive interface. Whether you work in prevention, treatment, recovery, public health, law enforcement, research or policy development, this resource provides an invaluable evidence base for planning programmes, informing policy decisions, supporting teaching, and strengthening advocacy with current global data.

We encourage ISSUP members to spend some time exploring this new resource and consider how it can support your own work. The interactive platform makes the wealth of information contained within the World Drug Report far more accessible and practical for everyday professional use.

If you were unable to join us live, or would simply like to revisit the discussion, you can watch the full webinar recording here:

ISSUP Webinar Recording: Highlights from the 2026 UNODC World Drug Report

To explore the complete report: UNODC World Drug Report 2026

For a practical overview of the interactive data tools and how they can support your work, ISSUP members may also find the interactive data platform helpful: Explore UNODC World Drug Report 2026: Drug Market Patterns and Trends Dashboard

As the 2026 World Drug Report reminds us, responding effectively to today’s drug landscape requires more than keeping pace with changing drug markets. It requires an equally agile, evidence-informed workforce capable of working collaboratively across prevention, treatment, recovery, research, policy and public safety. By continuing to strengthen these connections, we move closer to our shared goal of healthier individuals, safer communities, and more effective responses to the complex challenges posed by drugs worldwide.